Related Experiment Video
Updated: Apr 29, 2026

Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
Bionanoparticles Derived From Himalayan Herbs as Efficient Nanobiomedicines and Alternatives to Allopathic
Mohsina Mushtaq1, Jigneshkumar V Rohit1,2
1Department of Chemistry, National Institute of Technology Srinagar, Srinagar, Jammu and Kashmir, India.
Abstract:
The widespread use of allopathic medications has significantly improved modern healthcare; however, their associated side effects and the rapid emergence of antimicrobial resistance have intensified the search for safer and more effective therapeutic alternatives. In this context, natural resources, especially Himalayan medicinal herbs, have resurfaced as potential alternatives due to their therapeutic potency and biocompatibility. The Himalayan region offers a unique reservoir of bioactive plants suitable for biomedical applications based on nanotechnology. It is well known for its high biodiversity and traditional medicinal uses. This review assesses the biological applications of bionanoparticles derived from Himalayan herbs, including antibacterial, antifungal, antiviral, antiparasitic, antioxidant, antidiabetic, and anticancer properties. It also critically looks at recent developments in the green synthesis of these bionanoparticles. Furthermore, the mechanisms of action that explain their improved therapeutic efficacy are addressed. Overall, this review emphasizes the scientific value of Himalayan herb-based nanobiomedicines as viable, sustainable substitutes for traditional allopathic medications, as well as their potential for future biomedical applications.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Products: Biologics, Biosimilars and Interchangeables
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

